http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022262624-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_795cb009fbe52eb9be778ed97897534c
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2833
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0603
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6872
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-713
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
filingDate 2022-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b48fd478276e60ed2f1dc009ae63085a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f566c943cb379290738c9962e865d4c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_754c73847713b04d48d78aaf7f830be6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f2ec1893cb4fdcb165fd3029614e6bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4884533f3a487432f196cea3f3430f23
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c3cc6e710fa4b8b3ba07dc4cf92d5827
publicationDate 2022-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2022262624-A1
titleOfInvention PHARMACEUTICAL USE OF β2-MICROGLOBULIN OR INHIBITOR THEREOF
abstract The present invention belongs to the field of biomedicine, and relates to a pharmaceutical use of β2-microglobulin or an inhibitor thereof. In particular, the present invention relates to a use of β2-microglobulin or an inhibitor thereof in preparing a medicine for the treatment and/or prevention of Down's syndrome or Alzheimer's disease. β2-microglobulin can be used as an effective drug target for the prevention and treatment of Down's syndrome or Alzheimer's disease.
priorityDate 2021-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1741781-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017127537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1394549-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1263681
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4054
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226587093
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2954
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395069
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395070

Total number of triples: 47.